HEADER STRUCTURAL PROTEIN/INHIBITOR 20-MAR-12 4E91 TITLE CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HIV-1 CAPSID IN COMPLEX TITLE 2 WITH INHIBITOR BD3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GAG PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN, UNP RESIDUES 133-278; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 GENE: GAG; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS STRUCTURAL PROTEIN CAPSID, STRUCTURAL PROTEIN, STRUCTURAL PROTEIN- KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.T.LEMKE REVDAT 4 28-FEB-24 4E91 1 REMARK REVDAT 3 12-JUN-13 4E91 1 REMARK REVDAT 2 06-JUN-12 4E91 1 JRNL REVDAT 1 25-APR-12 4E91 0 JRNL AUTH C.T.LEMKE,S.TITOLO,U.VON SCHWEDLER,N.GOUDREAU,J.F.MERCIER, JRNL AUTH 2 E.WARDROP,A.M.FAUCHER,R.COULOMBE,S.S.BANIK,L.FADER,A.GAGNON, JRNL AUTH 3 S.H.KAWAI,J.RANCOURT,M.TREMBLAY,C.YOAKIM,B.SIMONEAU, JRNL AUTH 4 J.ARCHAMBAULT,W.I.SUNDQUIST,S.W.MASON JRNL TITL DISTINCT EFFECTS OF TWO HIV-1 CAPSID ASSEMBLY INHIBITOR JRNL TITL 2 FAMILIES THAT BIND THE SAME SITE WITHIN THE N-TERMINAL JRNL TITL 3 DOMAIN OF THE VIRAL CA PROTEIN. JRNL REF J.VIROL. V. 86 6643 2012 JRNL REFN ISSN 0022-538X JRNL PMID 22496222 JRNL DOI 10.1128/JVI.00493-12 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.T.LEMKE,S.TITOLO,N.GOUDREAU,A.M.FAUCHER,S.W.MASON, REMARK 1 AUTH 2 P.BONNEAU REMARK 1 TITL A NOVEL INHIBITOR-BINDING SITE ON THE HIV-1 CAPSID REMARK 1 TITL 2 N-TERMINAL DOMAIN LEADS TO IMPROVED CRYSTALLIZATION VIA REMARK 1 TITL 3 COMPOUND-MEDIATED DIMERIZATION. REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 69 1115 2013 REMARK 1 REFN ISSN 0907-4449 REMARK 1 PMID 23695256 REMARK 1 DOI 10.1107/S0907444913006409 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7_650) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.61 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 39464 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.221 REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1979 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.6149 - 4.0952 1.00 2948 133 0.2290 0.2714 REMARK 3 2 4.0952 - 3.2511 1.00 2803 147 0.2080 0.2123 REMARK 3 3 3.2511 - 2.8403 1.00 2747 165 0.2276 0.2500 REMARK 3 4 2.8403 - 2.5807 1.00 2723 166 0.2164 0.2371 REMARK 3 5 2.5807 - 2.3958 0.99 2728 128 0.2136 0.2288 REMARK 3 6 2.3958 - 2.2545 0.99 2679 156 0.2114 0.2153 REMARK 3 7 2.2545 - 2.1416 0.99 2711 133 0.2088 0.2326 REMARK 3 8 2.1416 - 2.0484 0.99 2670 126 0.2101 0.2463 REMARK 3 9 2.0484 - 1.9696 0.98 2689 135 0.2007 0.2306 REMARK 3 10 1.9696 - 1.9016 0.98 2634 136 0.2023 0.2281 REMARK 3 11 1.9016 - 1.8421 0.97 2613 144 0.2154 0.2779 REMARK 3 12 1.8421 - 1.7895 0.96 2578 145 0.2375 0.2747 REMARK 3 13 1.7895 - 1.7424 0.94 2518 137 0.2677 0.3440 REMARK 3 14 1.7424 - 1.7000 0.90 2444 128 0.3192 0.3274 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 0.90 REMARK 3 SHRINKAGE RADIUS : 0.61 REMARK 3 K_SOL : 0.37 REMARK 3 B_SOL : 48.77 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.180 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.350 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.23110 REMARK 3 B22 (A**2) : 0.23110 REMARK 3 B33 (A**2) : -0.46230 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2278 REMARK 3 ANGLE : 1.020 3106 REMARK 3 CHIRALITY : 0.062 329 REMARK 3 PLANARITY : 0.006 395 REMARK 3 DIHEDRAL : 18.892 862 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4E91 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-APR-12. REMARK 100 THE DEPOSITION ID IS D_1000071321. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC HIRES2 REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39464 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 57.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : 8.400 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : 0.37000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.7_650 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.76 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.7M NA/K TARTRATE, 0.1M BIS-TRIS REMARK 280 PH7.0, 0.2M NAI, 16% GLYEROL, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 284K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 95.54867 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 47.77433 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 47.77433 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 95.54867 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 5 REMARK 465 LEU A 6 REMARK 465 GLN A 7 REMARK 465 GLY A 8 REMARK 465 GLN A 9 REMARK 465 MET A 10 REMARK 465 HIS A 87 REMARK 465 ALA A 88 REMARK 465 GLY A 89 REMARK 465 PRO A 90 REMARK 465 ILE A 91 REMARK 465 ALA A 92 REMARK 465 PRO A 93 REMARK 465 GLY A 94 REMARK 465 GLN A 95 REMARK 465 VAL B 86 REMARK 465 HIS B 87 REMARK 465 ALA B 88 REMARK 465 GLY B 89 REMARK 465 PRO B 90 REMARK 465 ILE B 91 REMARK 465 ALA B 92 REMARK 465 PRO B 93 REMARK 465 GLY B 94 REMARK 465 GLN B 95 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE B 32 -14.58 77.32 REMARK 500 VAL B 59 -157.21 -93.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0OE A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0OF A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOD A 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOD A 205 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOD A 206 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0OE B 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4E92 RELATED DB: PDB DBREF 4E91 A 1 146 UNP Q79791 Q79791_9HIV1 133 278 DBREF 4E91 B 1 146 UNP Q79791 Q79791_9HIV1 133 278 SEQRES 1 A 146 PRO ILE VAL GLN ASN LEU GLN GLY GLN MET VAL HIS GLN SEQRES 2 A 146 ALA ILE SER PRO ARG THR LEU ASN ALA TRP VAL LYS VAL SEQRES 3 A 146 VAL GLU GLU LYS ALA PHE SER PRO GLU VAL ILE PRO MET SEQRES 4 A 146 PHE SER ALA LEU SER GLU GLY ALA THR PRO GLN ASP LEU SEQRES 5 A 146 ASN THR MET LEU ASN THR VAL GLY GLY HIS GLN ALA ALA SEQRES 6 A 146 MET GLN MET LEU LYS GLU THR ILE ASN GLU GLU ALA ALA SEQRES 7 A 146 GLU TRP ASP ARG LEU HIS PRO VAL HIS ALA GLY PRO ILE SEQRES 8 A 146 ALA PRO GLY GLN MET ARG GLU PRO ARG GLY SER ASP ILE SEQRES 9 A 146 ALA GLY THR THR SER THR LEU GLN GLU GLN ILE GLY TRP SEQRES 10 A 146 MET THR HIS ASN PRO PRO ILE PRO VAL GLY GLU ILE TYR SEQRES 11 A 146 LYS ARG TRP ILE ILE LEU GLY LEU ASN LYS ILE VAL ARG SEQRES 12 A 146 MET TYR SER SEQRES 1 B 146 PRO ILE VAL GLN ASN LEU GLN GLY GLN MET VAL HIS GLN SEQRES 2 B 146 ALA ILE SER PRO ARG THR LEU ASN ALA TRP VAL LYS VAL SEQRES 3 B 146 VAL GLU GLU LYS ALA PHE SER PRO GLU VAL ILE PRO MET SEQRES 4 B 146 PHE SER ALA LEU SER GLU GLY ALA THR PRO GLN ASP LEU SEQRES 5 B 146 ASN THR MET LEU ASN THR VAL GLY GLY HIS GLN ALA ALA SEQRES 6 B 146 MET GLN MET LEU LYS GLU THR ILE ASN GLU GLU ALA ALA SEQRES 7 B 146 GLU TRP ASP ARG LEU HIS PRO VAL HIS ALA GLY PRO ILE SEQRES 8 B 146 ALA PRO GLY GLN MET ARG GLU PRO ARG GLY SER ASP ILE SEQRES 9 B 146 ALA GLY THR THR SER THR LEU GLN GLU GLN ILE GLY TRP SEQRES 10 B 146 MET THR HIS ASN PRO PRO ILE PRO VAL GLY GLU ILE TYR SEQRES 11 B 146 LYS ARG TRP ILE ILE LEU GLY LEU ASN LYS ILE VAL ARG SEQRES 12 B 146 MET TYR SER HET 0OE A 201 38 HET 0OF A 202 38 HET IOD A 203 1 HET IOD A 204 1 HET IOD A 205 1 HET IOD A 206 1 HET 0OE B 201 38 HETNAM 0OE 4-{2-[5-(3-CHLOROPHENYL)-1H-PYRAZOL-4-YL]-1-[3-(1H- HETNAM 2 0OE IMIDAZOL-1-YL)PROPYL]-1H-BENZIMIDAZOL-5-YL}BENZOIC HETNAM 3 0OE ACID HETNAM 0OF (3S)-1-ETHYL-3-[3-HYDROXY-5-(PYRIDIN-3-YL)PHENYL]-5- HETNAM 2 0OF PHENYL-7-(TRIFLUOROMETHYL)-1H-1,5-BENZODIAZEPINE-2, HETNAM 3 0OF 4(3H,5H)-DIONE HETNAM IOD IODIDE ION FORMUL 3 0OE 2(C29 H23 CL N6 O2) FORMUL 4 0OF C29 H22 F3 N3 O3 FORMUL 5 IOD 4(I 1-) FORMUL 10 HOH *275(H2 O) HELIX 1 1 SER A 16 LYS A 30 1 15 HELIX 2 2 GLU A 35 SER A 44 1 10 HELIX 3 3 THR A 48 GLY A 60 1 13 HELIX 4 4 HIS A 62 HIS A 84 1 23 HELIX 5 5 ARG A 100 ALA A 105 1 6 HELIX 6 6 THR A 110 THR A 119 1 10 HELIX 7 7 PRO A 125 TYR A 145 1 21 HELIX 8 8 SER B 16 ALA B 31 1 16 HELIX 9 9 GLU B 35 SER B 44 1 10 HELIX 10 10 THR B 48 ASN B 57 1 10 HELIX 11 11 HIS B 62 HIS B 84 1 23 HELIX 12 12 ARG B 100 ALA B 105 1 6 HELIX 13 13 THR B 110 THR B 119 1 10 HELIX 14 14 PRO B 125 TYR B 145 1 21 SHEET 1 A 2 ILE B 2 GLN B 4 0 SHEET 2 A 2 MET B 10 HIS B 12 -1 O VAL B 11 N VAL B 3 CISPEP 1 ASN A 121 PRO A 122 0 3.13 CISPEP 2 ASN B 121 PRO B 122 0 1.62 SITE 1 AC1 19 TRP A 80 MET A 96 GLU A 98 TRP A 117 SITE 2 AC1 19 HIS A 120 PRO A 122 ILE A 124 PRO A 125 SITE 3 AC1 19 ILE A 129 ARG A 132 HOH A 311 HOH A 437 SITE 4 AC1 19 PRO B 34 GLU B 35 ILE B 37 PRO B 38 SITE 5 AC1 19 ILE B 135 ASN B 139 HOH B 308 SITE 1 AC2 23 TRP A 23 VAL A 27 GLU A 28 ALA A 31 SITE 2 AC2 23 PHE A 32 SER A 33 VAL A 36 PHE A 40 SITE 3 AC2 23 MET A 55 LEU A 56 GLY A 60 GLY A 61 SITE 4 AC2 23 HIS A 62 ALA A 65 MET A 66 ARG A 97 SITE 5 AC2 23 ARG A 100 ASP A 103 LEU A 138 ILE A 141 SITE 6 AC2 23 VAL A 142 HOH A 309 HOH A 336 SITE 1 AC3 1 ASN B 74 SITE 1 AC4 1 0OE B 201 SITE 1 AC5 1 ALA A 64 SITE 1 AC6 20 PRO A 34 GLU A 35 ILE A 37 PRO A 38 SITE 2 AC6 20 ILE A 135 ASN A 139 IOD A 205 TRP B 80 SITE 3 AC6 20 HIS B 84 MET B 96 GLU B 98 TRP B 117 SITE 4 AC6 20 HIS B 120 PRO B 122 ILE B 124 ARG B 132 SITE 5 AC6 20 HOH B 304 HOH B 305 HOH B 378 HOH B 402 CRYST1 65.783 65.783 143.323 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015201 0.008777 0.000000 0.00000 SCALE2 0.000000 0.017553 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006977 0.00000